Zentalis Pharmaceuticals, Inc. SEC filings ZNTL
Zentalis Pharmaceuticals, Inc. has 546 filings in SEC EDGAR's recent list, going back to Dec 19, 2017. Its latest annual report, Form ARS, was filed on Apr 30, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 6, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Aug 14, 2026 (other events). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 424B5 | Prospectus supplement | Aug 14, 2026 | — |
| 424B5 | Prospectus supplement | Aug 13, 2026 | — |
| S-8 | Employee stock plan registration | May 14, 2025 | — |
| S-3 | Shelf registration | Mar 26, 2025 | — |
| S-8 | Employee stock plan registration | Feb 29, 2024 | — |
| S-3ASR | Automatic shelf registration | Feb 29, 2024 | — |
| 424B5 | Prospectus supplement | Jun 15, 2023 | — |
| FWP | Free writing prospectus | Jun 15, 2023 | — |
| S-8 | Employee stock plan registration | Aug 9, 2022 | — |
| 424B5 | Prospectus supplement | May 16, 2022 | — |
| 424B5 | Prospectus supplement | Apr 27, 2022 | — |
| 424B5 | Prospectus supplement | Jun 30, 2021 | — |
| 424B5 | Prospectus supplement | Jun 28, 2021 | — |
| S-3ASR | Automatic shelf registration | May 4, 2021 | — |
| S-3 | Shelf registration | May 4, 2021 | — |
| S-8 | Employee stock plan registration | Mar 19, 2021 | — |
| 424B4 | Prospectus | Jul 31, 2020 | — |
| S-1/A | Amended registration statement | Jul 28, 2020 | — |
| S-1 | Registration statement | Jul 27, 2020 | — |
| S-8 | Employee stock plan registration | Apr 7, 2020 | — |
| 424B4 | Prospectus | Apr 6, 2020 | — |
| S-1MEF | Filing | Apr 2, 2020 | — |
| S-1/A | Amended registration statement | Mar 31, 2020 | — |
| S-1/A | Amended registration statement | Mar 30, 2020 | — |
| S-1 | Registration statement | Mar 6, 2020 | — |
Showing 25 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- ZNTL (Nasdaq)
- Fiscal year ends
- December 31
- Headquarters
- San Diego, CA
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1725160
- Former names
- Zentalis Pharmaceuticals, LLC (until Apr 6, 2020); Zeno Pharma, LLC (until Sep 5, 2019)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.